GL1X · GenesisL1 explorer

MolNFT v1 · #126769 · protein + DNA

New insights into the role of DNA shape on its recognition by P53 proteins (complex P53DBD-LHG1)

5MCT · Cellular tumor antigen P53: “New insights into the role of DNA shape on its recognition by P53 proteins (complex P53DBD-LHG1)”. X-ray diffraction, 2 ligands (FOR, ZN), 6 pockets (best druggability 0.65). MolNFT v1 #126769 on…

PDB
5MCT
Type
protein + DNA
Length
420 residues
Chains
3
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Cellular tumor antigen P53; DNA
UniProt
P04637
Ligands
FOR, ZN
Pockets
6 · best druggability 0.65

Structure

x-ray diffraction · 2 distinct chains · 10% helix, 34% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BCellular tumor antigen P53protein20010% helix, 34% strandP04637
CDNAdna20——

Ligands and binding sites

  • FOR · Formyl group · ligand · 2 copies · chains A, B
  • ZN · Zinc ion · metal · 2 copies · chains A, B
  • EDO · 1,2-ethanediol · additive · 6 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

6 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15050.650.7750empty
21680.410.7325empty
3530.370.8015EDO
4940.360.7518EDO
5850.360.7518empty

Interfaces

3 interfaces between chains.

  • A–B · 590 Ų buried · 11 hydrogen bonds · protein-protein
  • B–C · 317 Ų buried · 7 hydrogen bonds · protein-nucleic
  • A–C · 317 Ų buried · 7 hydrogen bonds · protein-nucleic

Modifications

Observed in the structure: 2 modified (nucleotide modification).

Compared structures

  • 5MCT · New Insights into the Role of DNA Shape on Its Recognition by p53 Proteins (complex… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.